retatrutide parkinson disease clinical trial Parkinson's drug therapies in the pipeline: 2015–2024 A new clinical trial from

doi: 10.1053/J.GASTRO.2015.02.006 181 KanagarathamCel AnsariYSLewisOLOettgenHC

Clin Respir J

In addition to intrinsic and idiosyncratic DILI, medications can also cause liver injury through various patterns, including steatohepatitis and neoplastic (anabolic steroid-induced or nodular regenerative hyperplasia) and vasculitis (azathioprine-induced hepatic sinusoidal obstruction syndrome) ( Fig

B12 supports energy production gradually

Many GLP-1-friendly options are highly processed and contain a lot of sodium, but theyre better than going through a drive-thru and getting a fast-food meal

The choice between injection and pill depends on which medicine is prescribed, personal preference, and overall health needs